Lidocaine Market Research Report - Global Forecast till 2027

Global Lidocaine Market: Information by Formulation (Injections, Creams, Ointments, Gels, Aerosol Liquids and others), by Application (Dentistry, Cardiac Arrhythmia, Epilepsy, Cosmetics and others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Others) by Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2027

ID: MRFR/Pharma/0800-CR | July 2019 | Region: Global | 117 pages

Please note that the assessment period of report has been updated from 2019-2025 to 2020-2027. Cordially fill the sample form for updated data.

Market Overview


Worldwide topical lidocaine market size is relied upon to acquire market development in the gauge time of 2021 to 2028. Market Research Future examinations the market is developing with a CAGR of 8.40% in the previously mentioned research gauge period. Developing business sectors and tremendous interests of lidocaine market size in innovative work are the components answerable for this market's development. 


Nonetheless, the rising number of medical procedures, expanding use of lidocaine in dental techniques, developing periodontal illnesses, and expanding dental transport executions likewise support the market development. Also, expanding interest for lidocaine definitions, expanding medical care consumption, and expanding maturing patient populaces go about as market development openings. In any case, challenging administrative arrangements may hamper the worldwide lidocaine bronchoscopy market size.


COVID 19 Analysis


The COVID-19 pandemic massively affects lifestyles across the world. Each business requires to take on the conflict on the two fronts- wellbeing and monetary, and should bear this season of the constrained downturn. With the worldwide monetary plunge running into trillions of dollars, hypotheses are overflowing that the recuperation period may run well ahead of schedule one year from now.


Companies overall attempt to check out the circumstance and take vital, though savvy, measures to counter the interest drop. The investigators are persistently considering the lidocaine market business sectors and drawing in with critical industry specialists to give our customers the best experiences in their business sectors.


Market Dynamics


Drivers


Expanding rates of torment and torment-related problems of lidocaine bronchoscopy market size combined with the heightening predominance of epilepsy and dental methodology in the United States are among the components driving the market area.


The great factors that drive the market are huge scope necessity for sedatives in medical procedures alongside expanding utilization of lidocaine hydrochloride in dental methods.


Restraints


Dazedness, dizziness, and spinal pain are a couple of delayed infusion consequences, and these are knowledgeable about not very many cases. This is assessed to limit the lidocaine market size infusion market. Besides, an absence of anesthesiologists in immature nations likewise hampers the lidocaine market.


Be that as it may, contraindications of lidocaine hydrochloride in patients who are oversensitive to neighborhood sedatives, particularly the amide-type, and results like characteristic and excessive touchiness among numerous others limit the lidocaine market development.


The early indications of lidocaine market harmfulness are connected to CNS excitation and incorporate circumoral and tongue shivering, dazedness, metallic taste, discombobulation, visual and hear-able aggravations.


Challenges


The lidocaine market report discusses data on the market's general presentation, difficulties, dangers, and openings that mirror the present and future lidocaine market scenario. Along with this, it spreads out subtleties on the most recent unofficial laws and standards that sway the market's development.


Cumulative growth


The lidocaine market share is relied upon to record a CAGR of 8.40% during the conjecture time frame. An increment in the number of surgeries performed worldwide, including dental methods, corrective medical procedures, and plastic medical procedures, is relied upon to advance development. The worldwide ascent in constant and intense agony related issues and different advantages related to lidocaine hydrochloride are a central point driving the market development.


Segment Overview


By application


According to the application, this lidocaine market report is again divided into various parts such as heart arrhythmia, epilepsy, dental procedure, and other applications.


By dosage form


The lidocaine manufacturers are again divided into various parts according to dosage forms such as patches, injectable, creams, and other dosage forms. 


By geographical region


According to the geographical region, this lidocaine market is again divided into parts such as Middle East & Africa, Europe, South America, Asia Pacific, and North America. 


Regional Analysis


On topographical assessment, America is encountering colossal development because of expanding the number of R&D exercises and medical procedures, expanding the interest of lidocaine details. Europe is required to be the second-biggest lidocaine bronchoscopy market size during the figure time frame because of an expanding number of generous patients, medical procedures, and an expansion in lidocaine appropriation infusions to be utilized as neighborhood sedatives during medical procedures. Asia-Pacific is assessed as the quickest developing business sector during the figure time frame because of expansion in several dental systems, therapeutic strategies, and plastic medical procedures.


Value chain analysis


The worldwide Lidocaine market size is expected to increase significantly during the gauge time frame, somewhere in the range of 2021 and 2025. In 2021, the market was developing at a consistent rate, and with the increasing appropriation of methodologies by vital participants, the market is required to ascend over the projected skyline.


Competitive Analysis


Topical Lidocaine market size serious scene gives subtleties by a contender. Subtleties included are organization outline, organization financials, market potential, income created, interest in innovative work, item dispatch, new market activities, worldwide presence, creation locales and offices, organization qualities, and shortcomings, clinical preliminaries pipelines, item endorsements, licenses, item width and expansiveness, application predominance, innovation lifesaver bend. The above information focuses gave simply identified with the organizations' center identified with Lidocaine market.


Major Key Players



  • SCILEX Pharmaceuticals, Inc.

  • Hisamitsu Pharmaceutical Co., Inc.

  • Jiangsu Tianji Pharmaceutical Co. Ltd.

  • SOFMEDICA

  • Perkin Elmer

  • Medline Industries, Inc. 

  • SonoScape Medical Corp.

  • Pfizer, Inc.

  • KARL STORZ.

  • Teikoku Pharma USA, Inc.

  • Endomed Systems

  • Actavis Labs UT Inc.

  • Dun & Bradstreet, Inc.

  • PENTAX Medical


The Global Lidocaine market examination is obliged to include improvement designs, genuine scene assessment, and key territories headway status. Improvement techniques and plans are analyzed similarly as collecting cycles, and cost structures are also taken apart.


The report also centers around worldwide significant driving industry players of Global Lidocaine Market Share giving data, such as organization profiles, item picture and detail, creation, value, limit, cost, income, and contact data. Upstream crude materials and gear and downstream interest investigation are additionally done. With tables and figures dissecting the overall Global Lidocaine Market Forecast, this exploration gives key measurements on the business's condition and is an important wellspring of direction and heading for organizations and people inspired by the market.


Recent Developments


Ongoing and intense torment related to dental systems is the most well-known justification for medical services offices, which makes it the first reason for uneasiness in patients, along these lines, contributing to a great extent to medical services costs. The previously mentioned factors look good for the portion's development.


The dental strategy section is required to record a worthwhile CAGR during the gauge time frame. This is essentially credited to the broad use of lidocaine hydrochloride injectable in various careful dental systems. An expansion in the predominance of dental problems, combined with the developing number of medical procedures performed, is the key driving component for this fragment.


Report Overview


The topical Lidocaine market size investigation incorporates serious examination, creation data examination and locale astute examination, applications, contender scene, utilization and income study, cost structure examination, value assessment, and income investigation up to 2028. This market report includes the utilization of the most recent apparatuses and strategies for investigating, breaking down, and assembling information and data. This Lidocaine market report performs efficient social events, recording and examining information about the issues identified with the promotion of merchandise and enterprises and serves the organizations with a superb statistical surveying report. The Lidocaine market report gives keen answers to unpredictable business challenges and starts an easy dynamic interaction.


District and country shrewd measurements of Lidocaine market from the time frame 2016-2026. While 2016 and 2017 have been used as authentic information, 2018 is viewed as the base year. 2019-2026 have been determined as conjectures.


Different sorts accessible for the utilization of the Lidocaine market have been dissected. The factual investigation has been directed on acquiring the individual portion of these sections.



  • Medical services Regulatory structure of every locale. 

  • Territorial up-coming Lidocaine marketutilizes standpoint. 

  • Status of ongoing preliminaries and improvements. 

  • The provincial predominance of utilizations and types has been planned.



Frequently Asked Questions (FAQ) :


Lidocaine market projected to grow at approximately 8.40% CAGR during the assessment period (2020-2027).

The valuation of the global Lidocaine market is estimated to increase to USD 2,038.12 MN by the end of 2025.

Rising incidences of dental caries & other periodontal diseases and growing applications for lidocaine in dental procedures, are major tailwinds pushing the growth of the global Lidocaine market.

North America holds the largest share in the global Lidocaine market, followed by Europe and the Asia Pacific, respectively.

Boston Scientific Corporation (US), Mylan Pharmaceuticals Inc. (US), Cogentix Medical, Fujifilm Holdings Corporation (Japan), Endo Pharmaceutical Inc. (US), Olympus Corporation (Japan), Sorrento Therapeutics, Inc. (US), PENTAX MEDICAL (Japan), Actavis Labs UT Inc. (US), Endomed Systems, Teikoku Pharma USA (US), KARL STORZ GmbH & Co. KG. (Germany), Pfizer, Inc. (US), SonoScape Medical Corp. (China), Medline Industries, Inc. (US), SOFMEDICA, Perkin Elmer (US), Jiangsu Tianji Pharmaceutical Co., Ltd. (Japan), Hisamitsu Pharmaceutical Co., Inc. (Japan), SCILEX Pharmaceuticals, Inc., are some of the top players operating in the global Lidocaine market.

1 Report Prologue

2 Executive Summary

3 Market Introduction

3.1 Definition 17

3.2 Scope of the Study 17

3.3 Assumptions & Limitations 17

3.3.1 Assumptions 17

3.3.2 Limitations 17

3.4 Market Structure 18

4 Research Methodology

4.1 Research Process 20

4.2 Primary Research 21

4.3 Secondary Research 22

4.4 Market Size Estimation 22

4.5 Forecast Model 23

5 Market Dynamics

5.1 Introduction 25

5.2 Drivers 25

5.2.1 Increasing Aging Patient Population 25

5.2.2 Increasing Application of Lidocaine in Dental Procedures 26

5.2.3 Increasing Incidences of Dental Caries and Other Periodontal Diseases 26

5.3 Restraints 27

5.3.1 Stringent Regulatory Policies 27

5.4 Opportunities 27

5.4.1 Ongoing Research and Development Activities 27

6 Market Factor Analysis

6.1.1 R&D and Designing 29

6.1.2 Manufacturing 29

6.1.3 Distribution & Sales 29

6.1.4 Post-Sales Monitoring 29

6.2 Porter’s Five Forces Model 30

6.2.1 Bargaining Power of Suppliers 30

6.2.2 Bargaining Power of Buyers 30

6.2.3 Threat of New Entrants 31

6.2.4 Threat of Substitutes 31

6.2.5 Intense Rivalry 31

7 Lidocaine Market, by Formulation

7.1 Overview 33

7.2 Injections 35

7.4 Creams 36

7.5 Ointments 36

7.7 Gels 37

7.8 Aerosol Liquids 37

8 Lidocaine Market, by Application

8.1 Overview 39

8.2 Dentistry 41

8.3 Cardiac Arrythmia 41

8.4 Epilepsy 42

8.5 Cosmetics 42

9 Lidocaine Market, by Distribution Channel

9.1 Overview 45

9.2 Hospital Pharmacies 46

9.3 Retail Pharmacies 47

10 Global Lidocaine Market, by Region

10.1 Overview 49

10.2 Americas 51

Lidocaine Market, by Formulation

Lidocaine Market, by Application

Lidocaine Market, by Distribution Channel

10.2.1 North America 53

Lidocaine Market, by Formulation

Lidocaine Market, by Application

Lidocaine Market, by Distribution Channel

10.2.1.1 US 56

Lidocaine Market, by Formulation

Lidocaine Market, by Application

Lidocaine Market, by Distribution Channel

10.2.1.2 Canada 57

Lidocaine Market, by Formulation

Lidocaine Market, by Application

Lidocaine Market, by Distribution Channel

10.2.2 Latin America 59

Lidocaine Market, by Formulation

Lidocaine Market, by Application

Lidocaine Market, by Distribution Channel

10.3 Europe 61

Lidocaine Market, by Formulation

Lidocaine Market, by Application

Lidocaine Market, by Distribution Channel

10.3.1 Western Europe 63

Lidocaine Market, by Formulation

Lidocaine Market, by Application

Lidocaine Market, by Distribution Channel

10.3.1.1 UK 66

Lidocaine Market, by Formulation

Lidocaine Market, by Application

Lidocaine Market, by Distribution Channel

10.3.1.2 France 67

Lidocaine Market, by Formulation

Lidocaine Market, by Application

Lidocaine Market, by Distribution Channel

10.3.1.3 Germany 69

Lidocaine Market, by Formulation

Lidocaine Market, by Application

Lidocaine Market, by Distribution Channel

10.3.1.4 Italy 70

Lidocaine Market, by Formulation

Lidocaine Market, by Application

Lidocaine Market, by Distribution Channel

10.3.1.5 Spain 72

Lidocaine Market, by Formulation

Lidocaine Market, by Application

Lidocaine Market, by Distribution Channel

10.3.1.6 Rest of Western Europe 73

Lidocaine Market, by Formulation

Lidocaine Market, by Application

Lidocaine Market, by Distribution Channel

10.3.2 Eastern Europe 75

Lidocaine Market, by Formulation

Lidocaine Market, by Application

Lidocaine Market, by Distribution Channel

10.4 Asia-Pacific 77

Lidocaine Market, by Formulation

Lidocaine Market, by Application

Lidocaine Market, by Distribution Channel

10.4.1 Japan 80

Lidocaine Market, by Formulation

Lidocaine Market, by Application

Lidocaine Market, by Distribution Channel

10.4.2 China 81

Lidocaine Market, by Formulation

Lidocaine Market, by Application

Lidocaine Market, by Distribution Channel

10.4.3 India 83

Lidocaine Market, by Formulation

Lidocaine Market, by Application

Lidocaine Market, by Distribution Channel

10.4.4 Australia 84

Lidocaine Market, by Formulation

Lidocaine Market, by Application

Lidocaine Market, by Distribution Channel

10.4.5 South Korea 86

Lidocaine Market, by Formulation

Lidocaine Market, by Application

Lidocaine Market, by Distribution Channel

10.4.6 Rest of Asia-Pacific 87

Lidocaine Market, by Formulation

Lidocaine Market, by Application

Lidocaine Market, by Distribution Channel

10.5 Middle East & Africa 89

Lidocaine Market, by Formulation

Lidocaine Market, by Application

Lidocaine Market, by Distribution Channel

10.5.1 Middle East 91

Lidocaine Market, by Formulation

Lidocaine Market, by Application

Lidocaine Market, by Distribution Channel

10.5.2 Africa 93

Lidocaine Market, by Formulation

Lidocaine Market, by Application

Lidocaine Market, by Distribution Channel

11 Competitive Landscape

11.1 Introduction 96

12 Company Profile

12.1 AstraZeneca 98

12.1.1 Company Overview 98

12.1.2 Financial Overview 98

12.1.3 Products/Services Offered 98

12.1.4 Key Developments 99

12.1.5 SWOT Analysis 99

12.1.6 Key Strategies 99

12.2 Glenmark Pharmaceuticals Limited 100

12.2.1 Financial Overview 100

12.2.2 Products/Services Offered 100

12.2.3 Key Developments 101

12.2.4 SWOT Analysis 101

12.2.5 Key Strategies 101

12.3 Teligent 102

12.3.1 Company Overview 102

12.3.2 Financial Overview 102

12.3.3 Products/Services Offered 103

12.3.4 Key Developments 103

12.3.5 SWOT Analysis 103

12.3.6 Key Strategies 103

12.4 Septodont Holding 104

12.4.1 Company Overview 104

12.4.2 Financial Overview 104

12.4.3 Products/Services Offered 104

12.4.4 Key Developments 104

12.4.5 SWOT Analysis 105

12.4.6 Key Strategies 105

12.5 Amneal Pharmaceuticals LLC 106

12.5.1 Company Overview 106

12.5.2 Financial Overview 106

12.5.3 Products/Services Offered 106

12.5.4 Key Developments 106

12.5.5 SWOT Analysis 107

12.5.6 Key Strategies 107

12.6 Taro Pharmaceutical Industries Ltd. 108

12.6.1 Company Overview 108

12.6.2 Financial Overview 108

12.6.3 Products/Services Offered 109

12.6.4 Key Developments 109

12.6.5 SWOT Analysis 109

12.6.6 Key Strategies 109

12.7 Cambrex Corporation 110

12.7.1 Company Overview 110

12.7.2 Financial Overview 110

12.7.3 Products/Services Offered 110

12.7.4 Key Developments 111

12.7.5 SWOT Analysis 111

12.7.6 Key Strategies 111

12.8 Centura Pharmaceuticals Store 112

12.8.1 Company Overview 112

12.8.2 Financial Overview 112

12.8.3 Products/Services Offered 112

12.8.4 Key Developments 112

12.8.5 SWOT Analysis 112

12.8.6 Key Strategies 112

12.9 Proficient Rx LP 113

12.9.1 Company Overview 113

12.9.2 Financial Overview 113

12.9.3 Products/Services Offered 113

12.9.4 Key Developments 113

12.9.5 SWOT Analysis 113

12.9.6 Key Strategies 113

13 Appendix

13.1 Discussion Blue Print 115

14 List of Tables

TABLE 1 MARKET SYNOPSIS 15

TABLE 2 PRIMARY INTERVIEWS 20

TABLE 3 PORTER’S FIVE FORCES ANALYSIS: GLOBAL LIDOCAINE MARKET 30

TABLE 4 GLOBAL LIDOCAINE MARKET, BY FORMULATION, 2020–2027 (USD MILLION) 34

TABLE 5 GLOBAL LIDOCAINE MARKET, FOR INJECTIONS BY REGION, 2020–2027 (USD MILLION) 35

TABLE 6 GLOBAL LIDOCAINE MARKET, FOR CREAMS, BY REGION, 2020–2027 (USD MILLION) 36

TABLE 7 GLOBAL LIDOCAINE MARKET, FOR OINTMENTS, BY REGION, 2020–2027 (USD MILLION) 36

TABLE 8 GLOBAL LIDOCAINE MARKET, FOR GELS, BY REGION, 2020–2027 (USD MILLION) 37

TABLE 9 GLOBAL LIDOCAINE MARKET, FOR AEROSOL LIQUIDS, BY REGION, 2020–2027 (USD MILLION) 37

TABLE 10 GLOBAL LIDOCAINE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 40

TABLE 11 GLOBAL LIDOCAINE MARKET, FOR DENTISTRY, BY REGION, 2020–2027 (USD MILLION) 41

TABLE 12 GLOBAL LIDOCAINE MARKET, FOR CARDIAC ARRYTHMIA, BY REGION, 2020–2027 (USD MILLION) 42

TABLE 13 GLOBAL LIDOCAINE MARKET, FOR EPILEPSY, BY REGION, 2020–2027 (USD MILLION) 42

TABLE 14 GLOBAL LIDOCAINE MARKET, FOR COSMETICS, BY REGION, 2020–2027 (USD MILLION) 43

TABLE 15 GLOBAL LIDOCAINE MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 45

TABLE 16 GLOBAL LIDOCAINE MARKET, FOR HOSPITAL PHARMACIES, BY REGION, 2020–2027 (USD MILLION) 46

TABLE 17 GLOBAL LIDOCAINE MARKET, FOR RETAIL PHARMACIES, BY REGION, 2020–2027 (USD MILLION) 47

TABLE 18 GLOBAL LIDOCAINE MARKET, BY REGION, 2020–2027 (USD MILLION) 49

TABLE 19 AMERICAS: LIDOCAINE MARKET, BY REGION, 2020–2027 (USD MILLION) 51

TABLE 20 AMERICAS: LIDOCAINE MARKET, BY FORMULATION, 2020–2027 (USD MILLION) 52

TABLE 21 AMERICAS: LIDOCAINE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 52

TABLE 22 AMERICAS: LIDOCAINE MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 53

TABLE 23 NORTH AMERICA: LIDOCAINE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 53

TABLE 24 NORTH AMERICA: LIDOCAINE MARKET, BY FORMULATION, 2020–2027 (USD MILLION) 54

TABLE 25 NORTH AMERICA: LIDOCAINE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 55

TABLE 26 NORTH AMERICA: LIDOCAINE MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 55

TABLE 27 US: LIDOCAINE MARKET, BY FORMULATION, 2020–2027 (USD MILLION) 56

TABLE 28 US: LIDOCAINE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 56

TABLE 29 US: LIDOCAINE MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 57

TABLE 30 CANADA: LIDOCAINE MARKET, BY FORMULATION, 2020–2027 (USD MILLION) 57

TABLE 31 CANADA: LIDOCAINE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 58

TABLE 32 CANADA: LIDOCAINE MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 58

TABLE 33 LATIN AMERICA: LIDOCAINE MARKET, BY FORMULATION, 2020–2027 (USD MILLION) 59

TABLE 34 LATIN AMERICA: LIDOCAINE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 59

TABLE 35 LATIN AMERICA: LIDOCAINE MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 60

TABLE 36 EUROPE: LIDOCAINE MARKET, BY REGION, 2020–2027 (USD MILLION) 61

TABLE 37 EUROPE: LIDOCAINE MARKET, BY FORMULATION, 2020–2027 (USD MILLION) 62

TABLE 38 EUROPE: LIDOCAINE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 62

TABLE 39 EUROPE: LIDOCAINE MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 63

TABLE 40 WESTERN EUROPE: LIDOCAINE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 63

TABLE 41 WESTERN EUROPE: LIDOCAINE MARKET, BY FORMULATION, 2020–2027 (USD MILLION) 64

TABLE 42 WESTERN EUROPE: LIDOCAINE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 65

TABLE 43 WESTERN EUROPE: LIDOCAINE MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 65

TABLE 44 UK: LIDOCAINE MARKET, BY FORMULATION, 2020–2027 (USD MILLION) 66

TABLE 45 UK: LIDOCAINE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 66

TABLE 46 UK: LIDOCAINE MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 67

TABLE 47 FRANCE: LIDOCAINE MARKET, BY FORMULATION, 2020–2027 (USD MILLION) 67

TABLE 48 FRANCE: LIDOCAINE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 68

TABLE 49 FRANCE: LIDOCAINE MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 68

TABLE 50 GERMANY: LIDOCAINE MARKET, BY FORMULATION, 2020–2027 (USD MILLION) 69

TABLE 51 GERMANY: LIDOCAINE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 69

TABLE 52 GERMANY: LIDOCAINE MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 70

TABLE 53 ITLAY: LIDOCAINE MARKET, BY FORMULATION, 2020–2027 (USD MILLION) 70

TABLE 54 ITLAY: LIDOCAINE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 71

TABLE 55 ITLAY: LIDOCAINE MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 71

TABLE 56 SPAIN: LIDOCAINE MARKET, BY FORMULATION, 2020–2027 (USD MILLION) 72

TABLE 57 SPAIN: LIDOCAINE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 72

TABLE 58 SPAIN: LIDOCAINE MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 73

TABLE 59 REST OF WESTERN EUROPE: LIDOCAINE MARKET, BY FORMULATION, 2020–2027 (USD MILLION) 73

TABLE 60 REST OF WESTERN EUROPE: LIDOCAINE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 74

TABLE 61 REST OF WESTERN EUROPE: LIDOCAINE MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 74

TABLE 62 EASTERN EUROPE: LIDOCAINE MARKET, BY FORMULATION, 2020–2027 (USD MILLION) 75

TABLE 63 EASTERN EUROPE: LIDOCAINE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 75

TABLE 64 EASTERN EUROPE: LIDOCAINE MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 76

TABLE 65 ASIA-PACIFIC: LIDOCAINE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 77

TABLE 66 ASIA-PACIFIC: LIDOCAINE MARKET, BY FORMULATION, 2020–2027 (USD MILLION) 78

TABLE 67 ASIA-PACIFIC: LIDOCAINE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 79

TABLE 68 ASIA-PACIFIC: LIDOCAINE MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 79

TABLE 69 JAPAN: LIDOCAINE MARKET, BY FORMULATION, 2020–2027 (USD MILLION) 80

TABLE 70 JAPAN: LIDOCAINE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 80

TABLE 71 JAPAN: LIDOCAINE MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 81

TABLE 72 CHINA: LIDOCAINE MARKET, BY FORMULATION, 2020–2027 (USD MILLION) 81

TABLE 73 CHINA: LIDOCAINE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 82

TABLE 74 CHINA: LIDOCAINE MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 82

TABLE 75 INDIA: LIDOCAINE MARKET, BY FORMULATION, 2020–2027 (USD MILLION) 83

TABLE 76 INDIA: LIDOCAINE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 83

TABLE 77 INDIA: LIDOCAINE MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 84

TABLE 78 AUSTRALIA: LIDOCAINE MARKET, BY FORMULATION, 2020–2027 (USD MILLION) 84

TABLE 79 AUSTRALIA: LIDOCAINE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 85

TABLE 80 AUSTRALIA: LIDOCAINE MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 85

TABLE 81 SOUTH KOREA: LIDOCAINE MARKET, BY FORMULATION, 2020–2027 (USD MILLION) 86

TABLE 82 SOUTH KOREA: LIDOCAINE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 86

TABLE 83 SOUTH KOREA: LIDOCAINE MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 87

TABLE 84 REST OF ASIA-PACIFIC: LIDOCAINE MARKET, BY FORMULATION, 2020–2027 (USD MILLION) 87

TABLE 85 REST OF ASIA-PACIFIC: LIDOCAINE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 88

TABLE 86 REST OF ASIA-PACIFIC: LIDOCAINE MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 88

TABLE 87 MIDDLE EAST & AFRICA: LIDOCAINE MARKET, BY REGION, 2020–2027 (USD MILLION) 89

TABLE 88 MIDDLE EAST & AFRICA: LIDOCAINE MARKET, BY FORMULATION, 2020–2027 (USD MILLION) 90

TABLE 89 MIDDLE EAST & AFRICA: LIDOCAINE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 90

TABLE 90 MIDDLE EAST & AFRICA: LIDOCAINE MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 91

TABLE 91 MIDDLE EAST: LIDOCAINE MARKET, BY FORMULATION, 2020–2027 (USD MILLION) 91

TABLE 92 MIDDLE EAST: LIDOCAINE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 92

TABLE 93 MIDDLE EAST: LIDOCAINE MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 92

TABLE 94 AFRICA: LIDOCAINE MARKET, BY FORMULATION, 2020–2027 (USD MILLION) 93

TABLE 95 AFRICA: LIDOCAINE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 93

TABLE 96 AFRICA: LIDOCAINE MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 94

TABLE 97 TOP MANUFACTURERS IN THE GLOBAL LIDOCAINE MARKET 96

15 List of Figures

FIGURE 1 GLOBAL LIDOCAINE MARKET: MARKET STRUCTURE 18

FIGURE 2 RESEARCH PROCESS 20

FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH 23

FIGURE 4 SUPPLY CHAIN: GLOBAL LIDOCAINE MARKET 29

FIGURE 5 GLOBAL LIDOCAINE MARKET SHARE, BY FORMULATION, 2020 (%) 34

FIGURE 6 GLOBAL LIDOCAINE MARKET, BY FORMULATION, 2020 & 2027 (USD MILLION) 35

FIGURE 7 GLOBAL LIDOCAINE MARKET SHARE, BY APPLICATION, 2020 (%) 40

FIGURE 8 GLOBAL LIDOCAINE MARKET, BY APPLICATION, 2020 & 2027 (USD MILLION) 41

FIGURE 9 GLOBAL LIDOCAINE MARKET SHARE, BY DISTRIBUTION CHANNEL, 2020 (%) 46

FIGURE 10 GLOBAL LIDOCAINE MARKET, BY DISTRIBUTION CHANNEL, 2020 & 2027 (USD MILLION) 46

FIGURE 11 GLOBAL LIDOCAINE MARKET SHARE, BY REGION, 2020 (%) 49

FIGURE 12 GLOBAL LIDOCAINE MARKET, BY REGION, 2020 & 2027 (USD MILLION) 50

FIGURE 13 AMERICAS: LIDOCAINE MARKET SHARE, BY REGION, 2020 (%) 51

FIGURE 14 NORTH AMERICA: LIDOCAINE MARKET SHARE, BY COUNTRY, 2020 (%) 54

FIGURE 15 EUROPE: LIDOCAINE MARKET SHARE, BY REGION, 2020 (%) 61

FIGURE 16 WESTERN EUROPE: LIDOCAINE MARKET SHARE, BY COUNTRY, 2020 (%) 64

FIGURE 17 ASIA-PACIFIC: LIDOCAINE MARKET SHARE, BY COUNTRY, 2020 (%) 78

FIGURE 18 MIDDLE EAST & AFRICA: LIDOCAINE MARKET SHARE, BY REGION, 2020 (%) 89